Optimal Furosemide Therapy in Critically Ill infants
- Publication date
- 7 June 2007
- Publisher
- Furosemide as continuous infusion is used in infants after
cardiopulmonary bypass (CPB) surgery and during extracorporeal
membrane oxygenation (ECMO). The currently used regimens which start
with low dose (0.05 - 0.1 mg/kg.hr) may not be optimal in this group
of patients with varying renal function.
In an observational study the pharmacokinetics/pharmacodynamics (PK/
PD) of continuous furosemide therapy were evaluated in infants after
CPB surgery. The study confirmed that the effects of furosemide are
dependent on renal function. Therefore it was hypothesized that
furosemide therapy may be more effective when the infusion is started
at a higher dose. With the data from the observational study a PK/PD
model was developed. The proposed furosemide regimen (loading bolus:
1-2 mg/kg; infusion rate 0.2 mg/kg.hr) by the PK/PD model was
evaluated in infants after CPB surgery. Since adaptation of the
furosemide doses was hardly needed, the proposed regimen seems rational.
In a retrospective study furosemide regimens used in neonates during
ECMO were evaluated. The regimens varied widely in continuous and
intermittent doses. Given the wide variety of doses used, the
regimens might not be optimal. Therefore more standardized and
efficacious dosing regimens should be developed. As CPB and ECMO are
comparable procedures the PK/PD model developed for infants after CPB
surgery might also be applicable for infants on ECMO.
In a prospective study the proposed furosemide regimen (loading
bolus: 1-2 mg/kg; infusion rate 0.2 mg/kg.hr) by the PK/PD model was
evaluated in infants during ECMO. The results suggest that the
proposed furosemide dose was too high, since the dose had to be
decreased in the majority of the patients. Therefore a novel PK/PD
model should be developed for infants on ECMO.
In conclusion the evaluated continuous furosemide regimens are safe
and effective to augment urine production in critically ill infants.
The PK/PD model developed for infants after CPB surgery should be
used with caution in infants treated with ECMO.